J. A. Barrera

发表

Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?

I. Chirivella, A. Lluch, A. Bosch, 2011, Breast.

Molecular Medicine in Practice PI 3 K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer

G. Mills, G. Hortobagyi, F. Meric-Bernstam, 2011 .

PI 3 K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer

G. Mills, G. Hortobagyi, F. Meric-Bernstam, 2011 .

Renal Functional Reserve in Patients with Recently Diagnosed Type 2 Diabetes mellitus with and without Microalbuminuria

J. Guízar, N. Amador, C. Kornhauser, 2001, Nephron.

PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer

G. Mills, G. Hortobagyi, F. Meric-Bernstam, 2011, Molecular Cancer Therapeutics.

UISESS scale for staging and classifying clinical–epidemiological risk in type 2 diabetes mellitus and for establishing multidiscipinary preventive actions

A. L. S. Rocha, J. A. Barrera, Cecilia Colunga Rodríguez, 2005 .

Cancer gene profile of metastatic breast cancer.

G. Mills, P. Stephens, R. Yelensky, 2012 .

Companion Diagnostics and Cancer Biomarkers Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer

G. Mills, P. Stephens, R. Yelensky, 2014 .

Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer

Funda Meric-Bernstam, Gordon B Mills, Xiaoping Su, 2014, Molecular Cancer Therapeutics.